Portal de Periódicos da CAPES

Performance of a Novel Point-of-Care Molecular Assay for Detection of Influenza A and B Viruses and Respiratory Syncytial Virus (Enigma MiniLab) in Children with Acute Respiratory Infection

2015; American Society for Microbiology; Volume: 54; Issue: 1 Linguagem: Inglês

10.1128/jcm.02887-15

1098-660X

Sam Douthwaite, Charlotte Walker, Elisabeth J Adams, Catherine Mak, Andres I. Vecino‐Ortiz, Nuria Martinez-Alier, Simon Goldenberg,

Influenza Virus Research Studies

ABSTRACT The performance of the Enigma MiniLab assay for influenza A and B viruses and respiratory syncytial virus (RSV) was compared to a centralized laboratory respiratory virus panel. The positive and negative percent agreement for influenza A virus, influenza B virus, and RSV were 79.2% (95% confidence interval [95% CI], 57.8 to 92.9%) and 99.4% (95% CI, 98.4 to 99.9), 100% (95% CI, 47.8 to 100%) and 100% (95% CI, 99.3 to 100%), 98.5% (95% CI, 94.6 to 99.8%) and 94.5% (95% CI, 91.9 to 96.4%), respectively.